To study the effect of DHODH inhibition on transcriptome profiling of CML cells, RNA-seq was performed after treatment of CML CD34+ cells with 100 nM Meds433 for 3 days. This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.